BACKGROUND: Several reports associate an Italian-style Mediterranean diet (IMD) with lower risk of cardiovascular disease and morbidity. The present study aimed to explore the effects of an Italian Mediterranean organic diet (IMOD) versus low-protein diet (LPD) in chronic kidney disease (CKD) patients, according to patients' carrier status for the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism. METHODS: A total of 40 male patients with CKD and stable renal function (Kidney Disease Outcomes Quality Initiative stages 2 and 3) were classified according to MTHFR polymorphism as carrier T(+) or non carrier T(-). At the time of enrolment (T0) patients' diet consisted of LPD; they were then administered IMD for 14 days (T1), thereupon IMOD for 14 days (T2). Patients underwent a complete medical history, body composition assessment and biochemical analysis. RESULTS: Baseline homocysteine levels were on average 8.24 mol/l higher (95 % confidence interval 6.47, 10.00) among T(+) than T(-) and the difference was statistically significant (p < 0.001). We found a significant interaction between MTHFR status and the effect of both the IMD and IMOD on homocysteine levels compared to LPD (p for interaction <0.001). Both the IMD and IMOD resulted in significant variations of anthropometric and laboratory measurements. CONCLUSIONS: IMD and IMOD diets could represent a viable alternative to LPD in CKD patients on conservative therapy. The effect of these diets seems to be influenced by MTHFR genotypes.
BACKGROUND: Several reports associate an Italian-style Mediterranean diet (IMD) with lower risk of cardiovascular disease and morbidity. The present study aimed to explore the effects of an Italian Mediterranean organic diet (IMOD) versus low-protein diet (LPD) in chronic kidney disease (CKD) patients, according to patients' carrier status for the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism. METHODS: A total of 40 male patients with CKD and stable renal function (Kidney Disease Outcomes Quality Initiative stages 2 and 3) were classified according to MTHFR polymorphism as carrier T(+) or non carrier T(-). At the time of enrolment (T0) patients' diet consisted of LPD; they were then administered IMD for 14 days (T1), thereupon IMOD for 14 days (T2). Patients underwent a complete medical history, body composition assessment and biochemical analysis. RESULTS: Baseline homocysteine levels were on average 8.24 mol/l higher (95 % confidence interval 6.47, 10.00) among T(+) than T(-) and the difference was statistically significant (p < 0.001). We found a significant interaction between MTHFR status and the effect of both the IMD and IMOD on homocysteine levels compared to LPD (p for interaction <0.001). Both the IMD and IMOD resulted in significant variations of anthropometric and laboratory measurements. CONCLUSIONS: IMD and IMOD diets could represent a viable alternative to LPD in CKDpatients on conservative therapy. The effect of these diets seems to be influenced by MTHFR genotypes.
Authors: A De Lorenzo; A Noce; M Bigioni; V Calabrese; D G Della Rocca; N Di Daniele; C Tozzo; Laura Di Renzo Journal: Curr Pharm Des Date: 2010 Impact factor: 3.116
Authors: Vandana Menon; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Jacob Selhub; Andrew S Levey; Mark J Sarnak Journal: Kidney Int Date: 2005-04 Impact factor: 10.612
Authors: Angelika de Bree; W M Monique Verschuren; Anne-Lise Bjørke-Monsen; Nathalie M J van der Put; Sandra G Heil; Frans J M Trijbels; Henk J Blom Journal: Am J Clin Nutr Date: 2003-03 Impact factor: 7.045
Authors: Roberto Senesi; Carla Andreani; Piero Baglioni; Luis A E Batista de Carvalho; Silvia Licoccia; Maria P M Marques; Giulia Moretti; Annalisa Noce; Roberto Paolesse; Stewart F Parker; Enrico Preziosi; Giovanni Romanelli; Annalisa Romani; Nicola Di Daniele Journal: Antioxidants (Basel) Date: 2021-04-22
Authors: Konstantinos C Makris; Corina Konstantinou; Xanthi D Andrianou; Pantelis Charisiadis; Alexis Kyriacou; Matthew O Gribble; Costas A Christophi Journal: PLoS One Date: 2019-09-04 Impact factor: 3.240